<DOC>
	<DOCNO>NCT01457469</DOCNO>
	<brief_summary>This randomize clinical trial study enhance quitline intervention smoke cessation patient non-metastatic lung cancer . Stop-smoking plan suggest doctor may help patient early-stage cancer quit smoking</brief_summary>
	<brief_title>Enhanced Quitline Intervention Smoking Cessation Patients With Non-Metastatic Lung Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To demonstrate feasibility deliver enhance quitline-based smoking cessation intervention lung cancer patient outpatient oncology set . SECONDARY OBJECTIVES : I . To gather preliminary outcome data enhance quitline-based smoking cessation intervention adapt outpatient oncology set support future grant application . II . To evaluate change primary patient report outcome , include quality life ( quantified Functional Assessment Cancer Therapy - Lung [ FACT-L ] European Organization Research Treatment Cancer Quality Life Questionnaire - Lung Cancer Module [ EORTC QLQ LC13 ] ) , perceive life stress ( quantify Perceived Stress Scale ) , depression ( quantified Center Epidemiological Studies Short Depression Scale [ CESD-10 ] ) , lung cancer patient intervention control condition ( control arm close accrual 3/6/2012 ) baseline 3-months following randomization . OUTLINE : Patients randomize 1 2 treatment arm . ARM I ( close accrual 3/6/2012 ) : Patients receive personalize letter physician advice quit smoke copy National Cancer Institute 's `` Cleaning Air '' smoke cessation booklet . ARM II : Patients receive personalize letter smoke cessation booklet . Patients also receive 8-week supply nicotine replacement patch undergo counsel session 30-45 minute train nurse midlevel provider focus benefit quit smoke cancer patient address cancer-specific concern smoke cessation . Patients also undergo quitline-based smoking cessation intervention comprise 5 individual 25- 30-minute telephone counseling session unlimited inbound phone-based access Quit Coaches 8-11 week , mail write material , interactive online program . After completion study treatment , patient follow 3 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Diagnosed American Joint Committee Cancer ( AJCC ) stage IIIIa/b nonsmall cell lung cancer limit stage small cell lung cancer Smoked cigarettes past seven day Willing consider quit smoking Patients drug alcohol abuse : All patient assess alcohol use use validate 1item screen question ; positive , patient assess use validated Alcohol Use Disorders Identification Test ( AUDIT ) screen instrument , score &gt; = 8 ( validate cutoff ) exclude All patient assess drug use use 1item screen question : `` How many time past month use illegal drug use prescription medication nonmedical reason ? `` ; response &gt; = 1 exclude Patient unable comprehend study document provide informed consent Eastern Cooperative Oncology Group ( ECOG ) performance status great two Patient read understand English Patient refuse participate Patient contraindicate receive nicotine replacement therapy : ) Patient pregnant breastfeeding , b ) Patient unstable cardiac disease within past month ( define unstable angina , myocardial infarction , serious arrhythmia , cardiac intervention procedure ) , c ) Patient currently take Chantix Patient regular access phone receive call quitline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>